“1nHealth’s expertise in digital recruitment played a pivotal role in connecting eligible participants through targeted campaigns, ensuring the process was efficient and reflective of real-world conditions.”

ObvioHealth

Ready. Set. Food! had spent years designing this trial, but needed a proven decentralized approach to reach their goal of 1,100 participants.

The EASE trial explores how early and consistent allergen introduction can address longstanding challenges parents face, such as sustaining allergen feeding and managing associated costs. Recruitment also needed total enrollment to be both ethnically and geographically diverse to provide true-to-life representation of the real world consumer base Ready. Set. Food! serves.

Messaging was one of the first things we wanted to get aligned with. We knew finding participants is the easy part — finding the right participants for this study is the challenge.

  • Parents and guardians concerned about infant’s health: This angle appealed to parents aiming to mitigate any potential health concerns or allergy development for their child.
  • Improving your child’s quality of life: This angle leads with quality-of-life improvements that can come if an allergy development is prevented.​
  • Pioneering research and helping others: This angle motivates individuals to make a difference for others like them while contributing to scientific advancements.​

“We are particularly proud of the fact that over 30% of our total enrollment is representative of minority or mixed race participants emulating the real world consumer base that we serve.”

Daniel Zakowski

CEO of Ready. Set. Food!

Even with a high submission rate (24.4%) one of the challenges we encountered was an unusually high number of disqualified referrals.

Our solution was to pinpoint that a frequent disqualification was due to age (8-10 weeks) and schedule re-invites once they were of qualifying age (11-19 weeks).​ We were able to convert 60% of those disqualifications into qualified referrals.

By owning every step of the enrollment process, 1nHealth was able to help deliver successful recruitment two months ahead of schedule.

We’re proud to contribute towards the advancement of research on early allergens to improve infant health outcomes and reduce healthcare costs around the world, all while maintaining the highest standards of integrity and data quality throughout every trial.

Want to read more case studies from 1nHealth?